81 FR 57917 - Health Insurance MarketplaceSM
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services Federal Register Volume 81, Issue 164 (August 24, 2016)
Centers for Medicare & Medicaid Services
Federal Register Volume 81, Issue 164 (August 24, 2016)
| Page Range | 57917-57919 | |
| FR Document | 2016-20187 |
[Federal Register Volume 81, Number 164 (Wednesday, August 24, 2016)] [Notices] [Pages 57917-57919] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-20187] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS-7042-N] Health Insurance Marketplace\SM\; and the Medicare, Medicaid, and Children's Health Insurance Programs; Meeting of the Advisory Panel on Outreach and Education (APOE), September 21, 2016 AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of meeting. ----------------------------------------------------------------------- SUMMARY: This notice announces the new meeting of the Advisory Panel on Outreach and Education (APOE) (the Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of Health Insurance Marketplace\SM\ and the Medicare, Medicaid, and Children's Health Insurance Programs consumer education strategies. This meeting is open to the public. DATES: Meeting Date: Wednesday, September 21, 2016, 8:30 a.m. to 4:00 p.m. eastern daylight time (e.d.t.). Deadline for Meeting Registration, Presentations, Special Accommodations and Comments: Wednesday, September 7, 2016, 5:00 p.m., e.d.t. ADDRESSES: Meeting Location: U.S. Department of Health & Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., Room 425A, Conference Room, Washington, DC 20201. Presentations and Written Comments: Presentations and written comments should be submitted to: Abigail Huffman, Designated Federal Official (DFO), Division of Forum and Conference Development, Office of Communications, Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Mailstop S1-05-06, Baltimore, MD 21244-1850 or via email at [email protected]. Registration: The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register at the Web site https://www.regonline.com/apoesept2016meeting or by contacting the DFO as listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations should contact the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: Abigail Huffman, Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1-05-06, Baltimore, MD 21244, 410-786-0897, email [email protected]. Additional information about the APOE is available on the Internet at: http://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690-6145. SUPPLEMENTARY INFORMATION: I. Background The Advisory Panel for Outreach and Education (APOE) (the Panel) is governed by the provisions of Federal Advisory Committee Act (FACA) (Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of federal advisory committees. The Panel is authorized by section 1114(f) of the Social Security Act (42 U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 U.S.C. 217a). The Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) signed the charter establishing the Citizen's Advisory Panel on Medicare Education \1\ (the predecessor to the APOE) on January 21, 1999 (64 FR 7899, February 17, 1999) to advise and make recommendations to the Secretary and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on the effective implementation of national Medicare education programs, including with respect to the Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 (Pub. L. 105-33). --------------------------------------------------------------------------- \1\ We note that the Citizen's Advisory Panel on Medicare Education is also referred to as the Advisory Panel on Medicare Education (65 FR 4617). The name was updated in the Second Amended Charter approved on July 24, 2000. --------------------------------------------------------------------------- The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173) expanded the existing health plan options and benefits available under the M+C program and renamed it the Medicare Advantage (MA) program. We have had substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options available and better tools to evaluate these options. The successful MA program implementation required CMS to consider the views and policy input from a variety of private sector constituents and to develop a broad range of public-private partnerships. In addition, Title I of the MMA authorized the Secretary and the Administrator of CMS (by delegation) to establish the Medicare prescription drug benefit. The drug benefit allows beneficiaries to obtain qualified prescription drug coverage. In order to effectively administer the MA program and the Medicare prescription drug benefit, we have substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options and benefits available, and to develop better tools to evaluate these plans and benefits. The Affordable Care Act (Patient Protection and Affordable Care Act, Public Law 111-148, and Health Care and Education Reconciliation Act of 2010, Public Law 111-152) expanded the availability of other options for health care coverage and enacted a number of changes to Medicare as well as to Medicaid and the Children's Health Insurance Program (CHIP). Qualified individuals and qualified employers are now able to purchase private health insurance coverage through competitive marketplaces, called Affordable Insurance Exchanges (we also call an Exchange a Health [[Page 57918]] Insurance Marketplace\SM\ \2\ or Marketplace\SM\). In order to effectively implement and administer these changes, we must provide information to consumers, providers, and other stakeholders through education and outreach programs regarding how existing programs will change and the expanded range of health coverage options available, including private health insurance coverage through a Marketplace\SM\. The APOE (the Panel) allows us to consider a broad range of views and information from interested audiences in connection with this effort and to identify opportunities to enhance the effectiveness of education strategies concerning the Affordable Care Act. --------------------------------------------------------------------------- \2\ Health Insurance Marketplace\SM\ and Marketplace\SM\ are service marks of the U.S. Department of Health & Human Services. --------------------------------------------------------------------------- The scope of this panel also includes advising on issues pertaining to the education of providers and stakeholders with respect to the Affordable Care Act and certain provisions of the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted as part of the American Recovery and Reinvestment Act of 2009 (ARRA). On January 21, 2011, the Panel's charter was renewed and the Panel was renamed the Advisory Panel for Outreach and Education. The Panel's charter was most recently renewed on January 21, 2015, and will terminate on January 21, 2017 unless renewed by appropriate action. Under the current charter, the APOE will advise the Secretary and the Administrator on optimal strategies for the following:Developing and implementing education and outreach programs for individuals enrolled in, or eligible for, Medicare, Medicaid, and CHIP or coverage available through the Health Insurance Marketplace\SM\. Enhancing the federal government's effectiveness in informing Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP consumers, issuers, providers, and stakeholders, through education and outreach programs, on issues regarding these programs, including the appropriate use of public-private partnerships to leverage the resources of the private sector in educating beneficiaries, providers, and stakeholders. Expanding outreach to vulnerable and underserved communities, including racial and ethnic minorities, in the context of Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP education programs. Assembling and sharing an information base of ``best practices'' for helping consumers evaluate health coverage options. Building and leveraging existing community infrastructures for information, counseling, and assistance. Drawing the program link between outreach and education, promoting consumer understanding of health care coverage choices, and facilitating consumer selection/enrollment, which in turn support the overarching goal of improved access to quality care, including prevention services, envisioned under the Affordable Care Act. The current members of the Panel are: Kellan Baker, Associate Director, Center for American Progress; Robert Blancato, President, Matz, Blancato & Associates; Dale Blasier, Professor of Orthopaedic Surgery, Department of Orthopaedics, Arkansas Children's Hospital; Deborah Britt, Executive Director of Community & Public Relations, Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of Pediatrics & Public Health, The Ohio State University, Nationwide Children's Hospital; Josephine DeLeon, Director, Anti-Poverty Initiatives, Catholic Charities of California; Robert Espinoza, Vice President of Policy, Paraprofessional Healthcare Institute; Jennifer Gross, Manager of Political Field Operations, Planned Parenthood of Montana; Louise Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Roanne Osborne-Gaskin, M.D., Senior Medical Director, MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation Support, Independent Contractor; Brendan Riley, Outreach and Enrollment Coordinator, NC Community Health Center Association; Alvia Siddiqi, Medical Director, Advocate Physician Partners; Carla Smith, Executive Vice President, Healthcare Information and Management Systems Society (HIMSS); Tobin Van Ostern, Vice President and Co-Founder, Young Invincibles Advisors; and Paula Villescaz, Senior Consultant, Assembly Health Committee, California State Legislature. II. Provisions of This Notice In accordance with section 10(a) of the FACA, this notice announces a meeting of the APOE. The agenda for the September 21, 2016 meeting will include the following: Welcome and listening session with CMS leadership Recap of the previous (June 22, 2016) meeting Affordable Care Act initiatives An opportunity for public comment Meeting summary, review of recommendations, and next steps Individuals or organizations that wish to make a 5-minute oral presentation on an agenda topic should submit a written copy of the oral presentation to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. The number of oral presentations may be limited by the time available. Individuals not wishing to make an oral presentation may submit written comments to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. III. Security, Building, and Parking Guidelines This meeting will be held in a federal government building; therefore, federal security measures are applicable. The Real ID Act, enacted in 2005, establishes minimum standards for the issuance of state-issued driver's licenses and identification (ID) cards. It prohibits federal agencies from accepting an official driver's license or ID card from a state unless the Department of Homeland Security determines that the state meets these standards. Beginning October 2015, photo IDs (such as a valid driver's license) issued by a state or territory not in compliance with the Real ID Act will not be accepted as identification to enter federal buildings. Visitors from these states/territories will need to provide alternative proof of identification (such as a valid passport) to gain entrance into CMS buildings. The current list of states from which a federal agency may accept driver's licenses for an official purpose is found at http://www.dhs.gov/real-id-enforcement-brief . We recommend that confirmed registrants arrive reasonably early, but no earlier than 45 minutes prior to the start of the meeting, to allow additional time to clear security. Security measures include the following: Presentation of government issued photographic identification to the Federal Protective Service or Guard Service personnel. Inspection of vehicle's interior and exterior (this includes engine and trunk inspection) at the entrance to the grounds. Parking permits and instructions will be issued after the vehicle inspection. Inspection, via metal detector or other applicable means, of all persons entering the building. We note that all items brought into CMS, whether personal or for the purpose of [[Page 57919]] presentation or to support a presentation, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set up, safety, or timely arrival of any personal belongings or items used for presentation or to support a presentation. Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. The public may not enter the building earlier than 45 minutes prior to the convening of the meeting. All visitors must be escorted in areas other than the lower and first floor levels in the Central Building. Authority: Sec. 222 of the Public Health Service Act (42 U.S.C. 217a) and sec. 10(a) of Pub. L. 92-463 (5 U.S.C. App. 2, sec. 10(a) and 41 CFR 102-3). Dated: August 16, 2016. Andrew M. Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2016-20187 Filed 8-23-16; 8:45 am] BILLING CODE 4120-01-P
![Federal Register / Vol. 81, No. 164 / Wednesday, August 24, 2016 / Notices 57917
open, responsive, and understandable to and Comments: Wednesday, September Panel on Medicare Education 1 (the
the public. We share the goal of 7, 2016, 5:00 p.m., e.d.t. predecessor to the APOE) on January 21,
increasing public participation in the ADDRESSES: Meeting Location: U.S. 1999 (64 FR 7899, February 17, 1999) to
development of Medicare coverage Department of Health & Human advise and make recommendations to
issues. This will assist us in obtaining Services, Hubert H. Humphrey Building, the Secretary and the Administrator of
the information we require to make a 200 Independence Avenue SW., Room the Centers for Medicare & Medicaid
national coverage determination in a 425A, Conference Room, Washington, Services (CMS) on the effective
timely manner and ensuring that the DC 20201. implementation of national Medicare
Medicare program continues to meet the Presentations and Written Comments: education programs, including with
needs of its beneficiaries. Form Number: Presentations and written comments respect to the Medicare+Choice (M+C)
CMS–R–290 (OMB control number: should be submitted to: Abigail program added by the Balanced Budget
0938–0776); Frequency: Annual; Huffman, Designated Federal Official Act of 1997 (Pub. L. 105–33).
Affected Public: Private Sector: Business (DFO), Division of Forum and The Medicare Modernization Act of
or other for-profits; Number of Conference Development, Office of
Respondents: 200; Total Annual 2003 (MMA) (Pub. L. 108–173)
Communications, Centers for Medicare expanded the existing health plan
Responses: 200; Total Annual Hours: & Medicaid Services, 7500 Security
8,000. (For policy questions regarding options and benefits available under the
Boulevard, Mailstop S1–05–06, M+C program and renamed it the
this collection contact Katherine Baltimore, MD 21244–1850 or via email
Tillman at 410–786–9252.) Medicare Advantage (MA) program. We
at Abigail.Huffman1@cms.hhs.gov. have had substantial responsibilities to
Dated: August 18, 2016. Registration: The meeting is open to provide information to Medicare
William N. Parham, III, the public, but attendance is limited to beneficiaries about the range of health
Director, Paperwork Reduction Staff, Office the space available. Persons wishing to plan options available and better tools
of Strategic Operations and Regulatory attend this meeting must register at the to evaluate these options. The
Affairs. Web site https://www.regonline.com/ successful MA program implementation
[FR Doc. 2016–20216 Filed 8–23–16; 8:45 am] apoesept2016meeting or by contacting required CMS to consider the views and
BILLING CODE 4120–01–P the DFO as listed in the FOR FURTHER policy input from a variety of private
INFORMATION CONTACT section of this
sector constituents and to develop a
notice, by the date listed in the DATES broad range of public-private
DEPARTMENT OF HEALTH AND section of this notice. Individuals partnerships.
HUMAN SERVICES requiring sign language interpretation or
other special accommodations should In addition, Title I of the MMA
Centers for Medicare & Medicaid contact the DFO at the address listed in authorized the Secretary and the
Services the ADDRESSES section of this notice by Administrator of CMS (by delegation) to
the date listed in the DATES section of establish the Medicare prescription drug
[CMS–7042–N] this notice. benefit. The drug benefit allows
FOR FURTHER INFORMATION CONTACT:
beneficiaries to obtain qualified
Health Insurance MarketplaceSM; and prescription drug coverage. In order to
Abigail Huffman, Designated Federal
the Medicare, Medicaid, and Children’s effectively administer the MA program
Official, Office of Communications,
Health Insurance Programs; Meeting of and the Medicare prescription drug
CMS, 7500 Security Boulevard, Mail
the Advisory Panel on Outreach and benefit, we have substantial
Stop S1–05–06, Baltimore, MD 21244,
Education (APOE), September 21, 2016 responsibilities to provide information
410–786–0897, email
AGENCY: Centers for Medicare & Abigail.Huffman1@cms.hhs.gov. to Medicare beneficiaries about the
Medicaid Services (CMS), HHS. Additional information about the APOE range of health plan options and
is available on the Internet at: http:// benefits available, and to develop better
ACTION: Notice of meeting.
www.cms.gov/Regulations-and- tools to evaluate these plans and
SUMMARY: This notice announces the Guidance/Guidance/FACA/APOE.html. benefits.
new meeting of the Advisory Panel on Press inquiries are handled through the The Affordable Care Act (Patient
Outreach and Education (APOE) (the CMS Press Office at (202) 690–6145. Protection and Affordable Care Act,
Panel) in accordance with the Federal SUPPLEMENTARY INFORMATION: Public Law 111–148, and Health Care
Advisory Committee Act. The Panel and Education Reconciliation Act of
advises and makes recommendations to I. Background 2010, Public Law 111–152) expanded
the Secretary of the U.S. Department of The Advisory Panel for Outreach and the availability of other options for
Health and Human Services (HHS) and Education (APOE) (the Panel) is health care coverage and enacted a
the Administrator of the Centers for governed by the provisions of Federal number of changes to Medicare as well
Medicare & Medicaid Services (CMS) on Advisory Committee Act (FACA) (Pub. as to Medicaid and the Children’s
opportunities to enhance the L. 92–463), as amended (5 U.S.C. Health Insurance Program (CHIP).
effectiveness of Health Insurance Appendix 2), which sets forth standards Qualified individuals and qualified
MarketplaceSM and the Medicare, for the formation and use of federal employers are now able to purchase
Medicaid, and Children’s Health advisory committees. The Panel is private health insurance coverage
Insurance Programs consumer education authorized by section 1114(f) of the through competitive marketplaces,
mstockstill on DSK3G9T082PROD with NOTICES
strategies. This meeting is open to the Social Security Act (42 U.S.C. 1314(f)) called Affordable Insurance Exchanges
public. and section 222 of the Public Health (we also call an Exchange a Health
DATES: Meeting Date: Wednesday, Service Act (42 U.S.C. 217a).
September 21, 2016, 8:30 a.m. to 4:00 The Secretary of the U.S. Department 1 We note that the Citizen’s Advisory Panel on
of Health and Human Services (HHS) Medicare Education is also referred to as the
p.m. eastern daylight time (e.d.t.). Advisory Panel on Medicare Education (65 FR
Deadline for Meeting Registration, (the Secretary) signed the charter 4617). The name was updated in the Second
Presentations, Special Accommodations establishing the Citizen’s Advisory Amended Charter approved on July 24, 2000.
VerDate Sep<11>2014 20:16 Aug 23, 2016 Jkt 238001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\24AUN1.SGM 24AUN1](https://thefederalregister.org/doc/81_FR_58081/page/1.svg)
![Federal Register / Vol. 81, No. 164 / Wednesday, August 24, 2016 / Notices 57919
presentation or to support a (HDE) applications, and de novo except for information submitted,
presentation, are subject to inspection. classification requests. This guidance marked and identified, as confidential,
We cannot assume responsibility for also discusses FDA’s inclusion of PPI in if submitted as detailed in
coordinating the receipt, transfer, its decision summaries and provides ‘‘Instructions.’’
transport, storage, set up, safety, or recommendations for the inclusion of Instructions: All submissions received
timely arrival of any personal such information in device labeling for must include the Docket No. FDA–
belongings or items used for certain devices. FDA is also issuing a 2015–D–1580 for ‘‘Patient Preference
presentation or to support a Level 2 updated version of the guidance Information—Voluntary Submission,
presentation. document entitled ‘‘Factors To Consider Review in PMAs, HDE Applications,
When Making Benefit-Risk and De Novo Requests, and Inclusion in
Note: Individuals who are not registered in
advance will not be permitted to enter the Determinations in Medical Device Decision Summaries and Device
building and will be unable to attend the Premarket Approval and De Novo Labeling.’’ If you are making
meeting. The public may not enter the Classifications,’’ originally issued on submissions that also address the edits
building earlier than 45 minutes prior to the March 28, 2012, that has been edited to to the Level 2 guidance, the submissions
convening of the meeting. be consistent with this guidance received must include the Docket No.
All visitors must be escorted in areas document. FDA–2011–D–0577 for ‘‘Factors To
other than the lower and first floor Consider When Making Benefit-Risk
DATES: Submit either electronic or Determinations in Medical Device
levels in the Central Building. written comments on this guidance at Premarket Approval and De Novo
Authority: Sec. 222 of the Public Health any time. General comments on Agency Classifications.’’ Received comments
Service Act (42 U.S.C. 217a) and sec. 10(a) guidance documents are welcome at any will be placed in the docket(s) noted
of Pub. L. 92–463 (5 U.S.C. App. 2, sec. 10(a) time. and, except for those submitted as
and 41 CFR 102–3). ADDRESSES: You may submit comments ‘‘Confidential Submissions,’’ publicly
Dated: August 16, 2016. as follows: viewable at http://www.regulations.gov
Andrew M. Slavitt, or at the Division of Dockets
Electronic Submissions
Acting Administrator, Centers for Medicare Management between 9 a.m. and 4 p.m.,
& Medicaid Services. Submit electronic comments in the Monday through Friday.
[FR Doc. 2016–20187 Filed 8–23–16; 8:45 am] following way: • Confidential Submissions—To
BILLING CODE 4120–01–P
• Federal eRulemaking Portal: http:// submit a comment with confidential
www.regulations.gov. Follow the information that you do not wish to be
instructions for submitting comments. made publicly available, submit your
DEPARTMENT OF HEALTH AND Comments submitted electronically, comments only as a written/paper
HUMAN SERVICES including attachments, to http:// submission. You should submit two
www.regulations.gov will be posted to copies total. One copy will include the
Food and Drug Administration the docket unchanged. Because your information you claim to be confidential
comment will be made public, you are with a heading or cover note that states
[Docket No. FDA–2015–D–1580]
solely responsible for ensuring that your ‘‘THIS DOCUMENT CONTAINS
Patient Preference Information— comment does not include any CONFIDENTIAL INFORMATION.’’ The
Voluntary Submission, Review in confidential information that you or a Agency will review this copy, including
Premarket Approval Applications, third party may not wish to be posted, the claimed confidential information, in
Humanitarian Device Exemption such as medical information, your or its consideration of comments. The
Applications, and De Novo Requests, anyone else’s Social Security number, or second copy, which will have the
and Inclusion in Decision Summaries confidential business information, such claimed confidential information
and Device Labeling; Guidance for as a manufacturing process. Please note redacted/blacked out, will be available
Industry, Food and Drug that if you include your name, contact for public viewing and posted on http://
Administration Staff and Other information, or other information that www.regulations.gov. Submit both
Stakeholders; Availability identifies you in the body of your copies to the Division of Dockets
comments, that information will be Management. If you do not wish your
AGENCY: Food and Drug Administration, posted on http://www.regulations.gov. name and contact information to be
HHS. • If you want to submit a comment made publicly available, you can
ACTION: Notice of availability. with confidential information that you provide this information on the cover
do not wish to be made available to the sheet and not in the body of your
SUMMARY: The Food and Drug public, submit the comment as a comments and you must identify this
Administration (FDA or Agency) is written/paper submission and in the information as ‘‘confidential.’’ Any
announcing the availability of the manner detailed (see ‘‘Written/Paper information marked as ‘‘confidential’’
guidance entitled ‘‘Patient Preference Submissions’’ and ‘‘Instructions’’). will not be disclosed except in
Information—Voluntary Submission, accordance with 21 CFR 10.20 and other
Review in PMAs, HDE Applications, Written/Paper Submissions applicable disclosure law. For more
and De Novo Requests, and Inclusion in Submit written/paper submissions as information about FDA’s posting of
Decision Summaries and Device follows: comments to public dockets, see 80 FR
Labeling.’’ This document explains the • Mail/Hand delivery/Courier (for 56469, September 18, 2015, or access
principal concepts that sponsors and written/paper submissions): Division of the information at: http://www.fda.gov/
mstockstill on DSK3G9T082PROD with NOTICES
other stakeholders should consider Dockets Management (HFA–305), Food regulatoryinformation/dockets/
when choosing to collect patient and Drug Administration, 5630 Fishers default.htm.
preference information (PPI), which Lane, Rm. 1061, Rockville, MD 20852. Docket: For access to the docket to
may inform FDA’s benefit-risk • For written/paper comments read background documents or the
determinations in the premarket review submitted to the Division of Dockets electronic and written/paper comments
of premarket approval applications Management, FDA will post your received, go to http://
(PMAs), humanitarian device exemption comment, as well as any attachments, www.regulations.gov and insert the
VerDate Sep<11>2014 20:16 Aug 23, 2016 Jkt 238001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\24AUN1.SGM 24AUN1](https://thefederalregister.org/doc/81_FR_58081/page/3.svg)
Document Created: 2016-08-24 03:02:33
Document Modified: 2016-08-24 03:02:33
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of meeting. | |
| Contact | Abigail Huffman, Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1-05-06, Baltimore, MD 21244, 410-786-0897, email [email protected] Additional information about the APOE is available on the Internet at: http://www.cms.gov/Regulations-and- Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690-6145. | |
| FR Citation | 81 FR 57917 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR